
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer
Wangyu Cai, Zi-Nan Dong, Xiao-Teng Fu, et al.
Theranostics (2020) Vol. 10, Iss. 19, pp. 8633-8647
Open Access | Times Cited: 63
Wangyu Cai, Zi-Nan Dong, Xiao-Teng Fu, et al.
Theranostics (2020) Vol. 10, Iss. 19, pp. 8633-8647
Open Access | Times Cited: 63
Showing 1-25 of 63 citing articles:
The Pyroptosis-Related Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Gastric Cancer
Wei Shao, Zongcheng Yang, Yue Fu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 157
Wei Shao, Zongcheng Yang, Yue Fu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 157
Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer
Hongbo Wang, Qinghai Meng, Jinjun Qian, et al.
Pharmacology & Therapeutics (2022) Vol. 234, pp. 108123-108123
Closed Access | Times Cited: 78
Hongbo Wang, Qinghai Meng, Jinjun Qian, et al.
Pharmacology & Therapeutics (2022) Vol. 234, pp. 108123-108123
Closed Access | Times Cited: 78
Application of artificial intelligence for improving early detection and prediction of therapeutic outcomes for gastric cancer in the era of precision oncology
Zhe Wang, Yang Liu, Xing Niu
Seminars in Cancer Biology (2023) Vol. 93, pp. 83-96
Closed Access | Times Cited: 41
Zhe Wang, Yang Liu, Xing Niu
Seminars in Cancer Biology (2023) Vol. 93, pp. 83-96
Closed Access | Times Cited: 41
Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma
Yuqin Tang, Chengbin Guo, Yang Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Yuqin Tang, Chengbin Guo, Yang Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Senescence as a dictator of patient outcomes and therapeutic efficacies in human gastric cancer
Lulin Zhou, Zubiao Niu, Yuqi Wang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 34
Lulin Zhou, Zubiao Niu, Yuqi Wang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 34
Cancer Stem Cells and the Tumor Microenvironment in Gastric Cancer
Ying Yang, Wenjian Meng, Ziqiang Wang
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 31
Ying Yang, Wenjian Meng, Ziqiang Wang
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 31
Artificial Intelligence in Gastrointestinal Cancer Research: Image Learning Advances and Applications
Shengyuan Zhou, Yi Xie, Xujiao Feng, et al.
Cancer Letters (2025) Vol. 614, pp. 217555-217555
Closed Access
Shengyuan Zhou, Yi Xie, Xujiao Feng, et al.
Cancer Letters (2025) Vol. 614, pp. 217555-217555
Closed Access
A novel identified epithelial ligand-receptor-associated gene signature highlights POPDC3 as a potential therapy target for non-small cell lung cancer
Xiaoren Zhu, Jiaqi Zhu, Qian-Hui Gu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Xiaoren Zhu, Jiaqi Zhu, Qian-Hui Gu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Comprehensive Analysis of Immune Implications and Prognostic Value of SPI1 in Gastric Cancer
Jianfeng Huang, Wenzheng Chen, Zhigang Jie, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23
Jianfeng Huang, Wenzheng Chen, Zhigang Jie, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23
Integrated Analysis of Multi-Omics Alteration, Immune Profile, and Pharmacological Landscape of Pyroptosis-Derived lncRNA Pairs in Gastric Cancer
Chunguang Guo, Zaoqu Liu, Yin Yu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 18
Chunguang Guo, Zaoqu Liu, Yin Yu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 18
Use of machine learning-based integration to develop an immune-related signature for improving prognosis in patients with gastric cancer
Jingyuan Ning, Keran Sun, Xiaoqing Fan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Jingyuan Ning, Keran Sun, Xiaoqing Fan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Immune landscape of hepatocellular carcinoma tumor microenvironment identifies a prognostic relevant model
Hongru Cao, Ping Huang, Jiawei Qiu, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24861-e24861
Open Access | Times Cited: 3
Hongru Cao, Ping Huang, Jiawei Qiu, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24861-e24861
Open Access | Times Cited: 3
Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates
Chengbin Guo, Yuqin Tang, Yang Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Chengbin Guo, Yuqin Tang, Yang Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of Gastric Cancer
Sutian Jiang, Yifan Zhang, Xiaojing Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
Sutian Jiang, Yifan Zhang, Xiaojing Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
Identification of circRNA–miRNA–Immune-Related mRNA Regulatory Network in Gastric Cancer
Zhenhai Wu, Pengyuan Liu, Ganlu Zhang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
Zhenhai Wu, Pengyuan Liu, Ganlu Zhang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
Artificial Intelligence-Assisted Transcriptomic Analysis to Advance Cancer Immunotherapy
Yu Gui, Xiujing He, Jing Yu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1279-1279
Open Access | Times Cited: 8
Yu Gui, Xiujing He, Jing Yu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1279-1279
Open Access | Times Cited: 8
Wnt signaling in gastric cancer: current progress and future prospects
Ruyue Han, Jing Yang, Yingying Zhu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Ruyue Han, Jing Yang, Yingying Zhu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Integrated single-cell and bulk RNA sequencing analyses identify an immunotherapy nonresponse-related fibroblast signature in gastric cancer
Qian Peng, Peiling Zhang, Guolong Liu, et al.
Anti-Cancer Drugs (2024) Vol. 35, Iss. 10, pp. 952-968
Closed Access | Times Cited: 2
Qian Peng, Peiling Zhang, Guolong Liu, et al.
Anti-Cancer Drugs (2024) Vol. 35, Iss. 10, pp. 952-968
Closed Access | Times Cited: 2
Identification of an Immune Gene-Associated Prognostic Signature and Its Association With a Poor Prognosis in Gastric Cancer Patients
Xiaoqing Guan, Zhiyuan Xu, Runzhe Chen, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 19
Xiaoqing Guan, Zhiyuan Xu, Runzhe Chen, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 19
Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data
Fangyuan Li, Jianfang Li, Junxian Yu, et al.
EBioMedicine (2021) Vol. 69, pp. 103436-103436
Open Access | Times Cited: 19
Fangyuan Li, Jianfang Li, Junxian Yu, et al.
EBioMedicine (2021) Vol. 69, pp. 103436-103436
Open Access | Times Cited: 19
Characterization of cellular senescence patterns predicts the prognosis and therapeutic response of hepatocellular carcinoma
Yuqin Tang, Chengbin Guo, Chuanliang Chen, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 13
Yuqin Tang, Chengbin Guo, Chuanliang Chen, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 13
A nomogram model based on the number of examined lymph nodes–related signature to predict prognosis and guide clinical therapy in gastric cancer
Huling Li, Dandan Lin, Zhen Yu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Huling Li, Dandan Lin, Zhen Yu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
A three-gene signature based on tumour microenvironment predicts overall survival of osteosarcoma in adolescents and young adults
Chun-Kai Wen, Hongxue Wang, Han Wang, et al.
Aging (2020) Vol. 13, Iss. 1, pp. 619-645
Open Access | Times Cited: 19
Chun-Kai Wen, Hongxue Wang, Han Wang, et al.
Aging (2020) Vol. 13, Iss. 1, pp. 619-645
Open Access | Times Cited: 19
Potential Therapeutic Action of Autophagy in Gastric Cancer Managements: Novel Treatment Strategies and Pharmacological Interventions
Md. Ataur Rahman, Kazi Rejvee Ahmed, MD. Hasanur Rahman, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 11
Md. Ataur Rahman, Kazi Rejvee Ahmed, MD. Hasanur Rahman, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 11
A Novel Exosome-Relevant Molecular Classification Uncovers Distinct Immune Escape Mechanisms and Genomic Alterations in Gastric Cancer
Yubiao Lin, Kaida Huang, Zhezhen Cai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Yubiao Lin, Kaida Huang, Zhezhen Cai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11